Clinical Trials on 类癌瘤 in Hong Kong
总计835个结果
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong终止
-
Chinese University of Hong Kong完全的
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany完全的
-
Chinese University of Hong Kong完全的
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong; Queen Mary Hospital... 和其他合作者主动,不招人
-
The University of Hong Kong未知
-
The University of Hong Kong未知NSCLC IV期 | EGFR激活突变 | 非小细胞肺癌 IIIB 期香港
-
Chinese University of Hong Kong尚未招聘
-
NovoCure GmbHZai Lab (Shanghai) Co., Ltd.未知
-
Chinese University of Hong Kong完全的
-
Chinese University of Hong KongHong Kong Nasopharyngeal Cancer Study Group Limited完全的
-
The University of Hong Kong招聘中复发性胶质母细胞瘤 | 复发性胶质瘤 | 聚 ADP 核糖聚合酶 (PARP) 抑制剂 | PTEN基因失活 | IDH突变香港
-
Dr Joanne CHIU招聘中ALK基因重排阳性 | EGF-R阳性非小细胞肺癌 | EGFR激活突变 | NSCLC | ROS1基因重排 | ROS1 阳性 NSCLC - 活性氧 1 阳性非小细胞肺癌香港
-
Hospital Authority, Hong KongSchering-Plough未知